Chief Financial Officer
Charles Jacques is the Chief Financial Officer, leading the global finance function for Cellistic and its affiliate Ncardia. In his new role, Charles leverages his experience in finance strategy for CDMO’s to help Cellistic accelerate its growth in the allogeneic immune cell therapy.
Previously, Charles worked for a strategy consulting firm, where he worked as director, specializing in fundraising and asset deals. Prior to this, Charles served in roles of increasing responsibility and finance leadership at MasTHerCell up to and after its acquisition by Catalent.